A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment
Authors:
- David F ArcherDADavid F Archer
- André LemayALAndré Lemay
- Ken WashenikKWKen Washenik
- Janet RobertsJRJanet Roberts
- Diane D HarrisonDHDiane D Harrison
- 1 September 2001
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 76 (3) , 461-468
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®)American Journal of Obstetrics and Gynecology, 1999
- Cycle control with oral contraceptives containing 20 μg of ethinyl estradiolContraception, 1999
- Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trialObstetrics & Gynecology, 1997
- A new low-dose monophasic combination oral contraceptive (Alesse™) with levonorgestrel 100 μg and ethinyl estradiol 20 μgContraception, 1997
- A multirater validation study to assess the reliability of acne lesion countingJournal of the American Academy of Dermatology, 1996
- Changes in androgens during treatment with four low-dose contractptivesContraception, 1996
- The evaluation and management of acne: Economic considerationsJournal of the American Academy of Dermatology, 1995
- Clinical Usefulness of Low-Dose Oral Contraceptives for the Treatment of Adolescent HyperandrogenemiaAsia-Oceania Journal of Obstetrics and Gynaecology, 1994
- Report of the consensus conference on acne classificationJournal of the American Academy of Dermatology, 1991
- Current Views on the Aetiology, Pathogenesis and Treatment of Acne VulgarisDrugs, 1990